Regenxbio (RGNX) Receivables - Net (2014 - 2026)
Regenxbio (RGNX) posted quarterly Receivables - Net of $28.7 million for Q4 2025, up 36.97% year-over-year from $20.9 million in Q4 2024, and up 2.06% quarter-over-quarter from $28.1 million in Q3 2025.
Regenxbio (RGNX) Receivables - Net (2014 - 2026) Analysis & Trends
Regenxbio's Receivables - Net history runs 12 years deep, the most recent figure standing at $28.7 million for Q4 2025.
- In Q4 2025, Receivables - Net rose 36.97% year-over-year to $28.7 million; the TTM figure through Dec 2025 stood at $28.7 million (up 36.97% YoY), while the FY2025 annual figure was $28.7 million, up 36.97% from the prior year.
- Receivables - Net for Q4 2025 stood at $28.7 million, up from $28.1 million in the prior quarter.
- The five-year high for Receivables - Net was $48.7 million in Q3 2021, with the low at $16.4 million in Q1 2024.
- The 5-year median for Receivables - Net is $28.4 million (2025), against an average of $29.3 million.
- The sharpest annual moves came in 2021 and 2025: Receivables - Net plunged 61.21% in 2021, then jumped 36.97% in 2025.
- Regenxbio's Receivables - Net stood at $34.7 million in 2021, then retreated by 14.74% to $29.6 million in 2022, then retreated by 13.84% to $25.5 million in 2023, then declined by 17.83% to $20.9 million in 2024, then surged by 36.97% to $28.7 million in 2025.
- Business Quant data shows RGNX's Receivables - Net at $28.7 million in Q4 2025, $28.1 million in Q3 2025, and $21.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Regenxbio | 583.35 Mn | 477.83 Mn | 106.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 107.19 Mn |
| Jun 30, 2026 | 107.19 Mn |
| Dec 31, 2025 | 28.69 Mn |
| Dec 31, 2025 | 28.69 Mn |
| Sep 30, 2025 | 28.11 Mn |
| Sep 30, 2025 | 28.11 Mn |
| Jun 30, 2025 | 21.78 Mn |
| Jun 30, 2025 | 21.78 Mn |
| Mar 31, 2025 | 19.40 Mn |
| Mar 31, 2025 | 19.40 Mn |
| Dec 31, 2024 | 20.95 Mn |
| Dec 31, 2024 | 20.95 Mn |
| Sep 30, 2024 | 24.01 Mn |
| Sep 30, 2024 | 24.01 Mn |
| Jun 30, 2024 | 23.27 Mn |
| Jun 30, 2024 | 23.27 Mn |
| Mar 31, 2024 | 16.35 Mn |
| Mar 31, 2024 | 16.35 Mn |
| Dec 31, 2023 | 25.49 Mn |
| Dec 31, 2023 | 25.49 Mn |